Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

April

Armstrong

,

MD, MPH

Chief, Division of Dermatology
University of California Los Angeles
Los Angeles
,
California
,
United States
Councilor Since: March 1, 2014
IPC Councilor
Dr. April Armstrong is the Chief of the Division of Dermatology at UCLA Health and the David Geffen School of Medicine at UCLA (DGSOM). She obtained her medical degree from Harvard Medical School and completed her dermatology residency at Harvard. She also received a Master of Public Health degree from the Harvard School of Public Health. Prior to joining the faculty at the University of Southern California, Dr. Armstrong was Vice-Chair at the University of California Davis and later at the University of Colorado.

Dr. Armstrong’s clinical expertise lies in inflammatory skin diseases, especially psoriasis and atopic dermatitis. She has conducted over 150 clinical trials and published over 350 high-impact articles in scientific journals. She holds multiple leadership positions in professional societies, serving as the Chair of the Medical Board of the National Psoriasis Foundation (NPF), Co-president for the Group in Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), a Councilor for both the International Eczema Council (IEC) and the International Psoriasis Council (IPC), and board director for the American Academy of Dermatology (AAD). Dr. Armstrong has also served on the editorial boards for JAMA Dermatology and the Journal of the American Academy of Dermatology (JAAD).
Last Updated:
10/19/2023

Languages Spoken

English

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026